View Archived Issues

May 25, 2018

Vol. 17
No. 102


Editor's Note

In observance of the Memorial Day holiday, Drug Industry Daily will not be published Monday, May 28. The next issue will be published Tuesday, May 29. Read More

Pfizer Agrees to Pay Nearly $24 Million to Put Kickback Claims to Rest

Pfizer agreed to pay $23.85 million and enter into a five-year corporate integrity agreement to settle U.S. government claims that the company engaged in illegal kickbacks to Medicare patients that were masked by an independent charity. Read More

Administration Urges SCOTUS to Review Merck Case Over Failure-to-Warn Claims

The Trump administration is urging the Supreme Court to take up a case testing whether the FDA’s refusal to approve a warning label on drugs preempts state laws that may require such labels. Read More

U.S. Cancer Drug Spending Nearly Doubled From 2017: IQVIA

Spending on U.S. cancer medicines nearly doubled over the last five years—and may well double again in the next five years, a new report from IQVIA claims. Read More